In vitro activity of cefovecin, extended-spectrum cephalosporin, against 284 clinical isolates collected from cats and dogs in Croatia

被引:0
|
作者
Seol, Branka [1 ]
Matanovic, Kresimir
Mekic, Selma
Staresina, Vilim
机构
[1] Univ Zagreb, Dept Microbiol, Zagreb 10000, Croatia
关键词
cefovecin; antimicrobial susceptibility; disk-diffusion; Staphylococcus pseudintermedius; E; coli; Proteus spp; EFFICACY; SAFETY; PHARMACOKINETICS; INFECTIONS;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
During the six-month collection period, 284 bacterial strains were recovered from different clinical samples from cats and dogs. Susceptibility to cefovecin was determined by disk-diffusion method. Out of 284 bacterial isolates, 202 were gram-positive bacteria and 82 were gram-negative. The most frequently isolated bacterial species was gram-positive Staphylococcus pseudintermedius (152), followed by streptococci (50). The most common gram-negative bacteria were Pseudomonas aeruginosa (26), Proteus spp. (25) and E. coli (22). The highest resistance among gram-positive bacteria was observed in non-hemolytic streptococci (50%) and Staphylococcus pseudintermedius (7.2%). Beta-hemolytic streptococci were 100% sensitive to cefovecin. As expected, cefovecin did not show any activity against P aeruginosa. Besides that, the highest resistance was shown by E. coli (40.9%) and Proteus spp. (8%). All P multocida isolates were sensitive to cefovecin. The results of the conducted survey show no significant differences of cefovecin activity against beta-hemolytic streptococci and P multocida isolates from EU and USA compared to Croatian strains, when tested by the broth microdilution and disk-diffusion method. However, resistance rates in S. pseudintermedius, E. coli and Panel's spp. are much higher among the Croatian strains.
引用
收藏
页码:91 / 97
页数:7
相关论文
共 50 条
  • [21] Activity of nine antimicrobial agents against clinical isolates of Klebsiella pneumoniae producing extended-spectrum β-lactamases and deficient or not in porins
    Doménech-Sánchez, A
    Pascual, A
    Suárez, AI
    Alvarez, D
    Benedí, VJ
    Martínez-Martínez, L
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (05) : 858 - 860
  • [22] Antibacterial In-vitro-Activity of Essential Oils against Clinical Isolates of Bacteria relevant for Veterinary Medicine from Dogs, Cats, and Horses
    Bismarck, Doris
    Schneider, Marianne
    Mueller, Elisabeth
    COMPLEMENTARY MEDICINE RESEARCH, 2017, 24 (03) : 153 - 163
  • [23] Activity of doripenem against extended-spectrum β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates
    Betriu, C.
    Gomez, M.
    Lopez-Fabal, F.
    Culebras, E.
    Rodriguez-Avial, I.
    Picazo, J. J.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2010, 29 (09) : 1179 - 1181
  • [24] Activity of doripenem against extended-spectrum β-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa isolates
    C. Betriu
    M. Gómez
    F. López-Fabal
    E. Culebras
    I. Rodríguez-Avial
    J. J. Picazo
    European Journal of Clinical Microbiology & Infectious Diseases, 2010, 29 : 1179 - 1181
  • [25] In vitro activity of premafloxacin, a new extended-spectrum fluoroquinolone, against pathogens of veterinary importance
    Watts, JL
    Salmon, SA
    Sanchez, MS
    Yancey, RJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1190 - 1192
  • [26] Underlying Mechanism of In vivo and In vitro Activity of C-terminal-amidated Thanatin Against Clinical Isolates of Extended-Spectrum β-lactamase-Producing Escherichia coli
    Hou, Zheng
    Lu, Jun
    Fang, Chao
    Zhou, Ying
    Bai, Hui
    Zhang, Xiaogong
    Xue, Xiaoyan
    Chen, Yingying
    Luo, Xiaoxing
    JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (02): : 273 - 282
  • [27] In vitro activity of β-lactam and non-β-lactam antibiotics in extended-spectrum β-lactamase-producing clinical isolates of Escherichia coli
    Puerto, AS
    Fernández, JG
    del Castillo, JDL
    Pino, MJS
    Angulo, GP
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2006, 54 (02) : 135 - 139
  • [28] Activity of tigecycline against clinical isolates of Staphylococcus aureus and extended-spectrum β-lactamase-producing Escherichia coli in Granada, Spain
    Sorlozano, A.
    Gutierrez, J.
    Salmeron, A.
    Luna, J. D.
    Martinez-Checa, F.
    Roman, J.
    Piedrola, G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2006, 28 (06) : 532 - 536
  • [29] Extended-spectrum β-lactamases in Escherichia coli isolated from dogs and cats in Rome, Italy, from 2001 to 2003
    Carattoli, A
    Lovari, S
    Franco, A
    Cordaro, G
    Di Matteo, P
    Battisti, A
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) : 833 - 835
  • [30] High diversity of extended-spectrum β-lactamases among clinical isolates of Enterobacteriaceae from Portugal
    Machado, Elisabete
    Coque, Teresa M.
    Canton, Rafael
    Novais, Angela
    Sousa, Joao Carlos
    Baquero, Fernando
    Peixe, Luisa
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1370 - 1374